{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:50:18Z","timestamp":1782460218815,"version":"3.54.5"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>A 25-year-old woman, gravida 3 para 2 at 12 weeks of gestation, with two prior cesarean deliveries, presents for prenatal care. She is in treatment for opioid use disorder on extended-release naltrexone injection, with a history of opioid overdose, relapse, and poor treatment adherence on methadone and buprenorphine. She asks, \u201cIs it safe for my baby if I continue on this medication? How will you manage my postoperative pain?\u201d<\/jats:p>","DOI":"10.1097\/aog.0000000000002864","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T20:27:44Z","timestamp":1537993664000},"page":"923-925","source":"Crossref","is-referenced-by-count":11,"title":["Pregnancy and Naltrexone Pharmacotherapy"],"prefix":"10.1097","volume":"132","author":[{"given":"Cresta W.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists.","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicenter, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijgo.2003.10.001","article-title":"Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user","volume":"85","author":"Hulse","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40265-017-0762-9","article-title":"A retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone, or sublingual buprenorphine, and non-dependent controls","volume":"77","author":"Kelty","year":"2017","journal-title":"Drugs"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40265-017-0763-8","article-title":"A retrospective cohort study of birth outcomes in neonates exposed to naltrexone in utero: a comparison with methadone-, buprenorphine-, and non-opioid-exposed neonates","volume":"77","author":"Kelty","year":"2017","journal-title":"Drugs"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/ajad.12642","article-title":"A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control children","volume":"26","author":"Kelty","year":"2017","journal-title":"Am J Addict"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0890334404266881","article-title":"Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk","volume":"20","author":"Chan","year":"2004","journal-title":"J Hum Lact"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00063110-200610000-00017","article-title":"Analgesia and sedation in the presence of a naltrexone implant: a novel pharmacological challenge","volume":"13","author":"O\u2019Brien","year":"2006","journal-title":"Eur J Emerg Med"},{"key":"R11-20230711","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000003477","article-title":"Opioid use disorders: perioperative management of a special population","author":"Ward","year":"2018 May 25","journal-title":"Anesth Analg"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:17:18Z","timestamp":1689103038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002864","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}